ARKK vs DGX
ARK Innovation ETF (ARKK) versus Quest Diagnostics Incorporated (DGX) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
ARKK does not have a complete income-statement cache yet.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
ARKK currently screens at market cap $0. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Not investment advice. Open the ARKK and DGX stock pages for the full models.
Not investment advice.